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Structure of the Hemagglutinin Precursor Cleavage
Site, a Determinant of Influenza Pathogenicity
and the Origin of the Labile Conformation
and Rott, 1987; Klenk and Rott, 1988; Klenk and Garten,
1994); its inhibition presents a target for antiviral agents
(Garten et al., 1989; Stieneke-Grober et al., 1992).
The conformation of the precursor HA0 is stable at
low pH, but cleaved HA is apparently metastable (Bul-
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²Howard Hughes Medical Institute lough et al., 1994). Once cleaved, HA is sensitive to
Cambridge, Massachusetts 02138 pH, undergoing an irreversible conformational change
³Laboratory of Molecular Medicine (Skehel et al., 1982) at the low pH of endosomes that is
Department of Medicine required for membrane fusion. The low-pH-induced con-
The Children's Hospital and formation melts at a higher temperature than the original
²Howard Hughes Medical Institute conformation (Ruigrok et al., 1988) and is achieved
Boston, Massachusetts 02115 spontaneously at neutral pH by soluble HA2 expressed
§National Institute for Medical Research in bacteria, suggesting that it is the lowest energy con-
The Ridgeway formation (Chen et al., 1995; Carr et al., 1997). The low-
Mill Hill, London NW7 1AA pH-induced conformational change is a dramatic re-
United Kingdom folding of HA2 that both projects the N-terminal fusion
peptide 100 AÊ to the end of a long coiled-coil rod (Carr
and Kim, 1993; Bullough et al., 1994) and relocates the
Summary C-terminal anchor, by a fold-back mechanism, to the
same end of the rod-shaped molecule (Bullough et al.,
The membrane fusion potential of influenza HA, like 1994). In the process of membrane fusion, this confor-
many viral membrane-fusion glycoproteins, is gener- mational change brings the target membrane±inserted
ated by proteolytic cleavage of a biosynthetic precur- fusion peptide near the transmembrane sequence an-
sor. The three-dimensional structure of ectodomain chored in the viral membrane (Weissenhorn et al., 1997).
of the precursor HA0 has been determined and com- A rod-like molecular shape with membrane attachments
pared with that of cleaved HA. The cleavage site is all at one end has also been found in ectodomain frag-
a prominent surface loop adjacent to a novel cavity; ments of HIV-1 gp41 (Chan et al., 1997; Tan et al., 1997;
cleavage results in structural rearrangements in which Weissenhorn et al., 1997) and the complex of v- and
the nonpolar amino acids near the new amino terminus t-SNAREs that fuses synaptic vesicles (Hanson et al.,
bury ionizable residues in the cavity that are implicated
1997; Weber et al., 1998). The structure of HA0 reported
in the low-pH-induced conformational change. Amino
here addresses both the origin of the labile HA confor-
acid insertions at the cleavage site in HAs of virulent
mation and its sensitivity to low pH.avian viruses and those of viruses isolated from the
Mammalian and apathogenic avian influenza virusrecent severe outbreak of influenza in humans in Hong
strains cause anatomically localized infections as a re-Kong would extend this surface loop, facilitating intra-
sult of the restricted range of cells secreting a proteasecellular cleavage.
that can cleave the HA0 precursor extracellularly (Klenk
et al., 1993). Highly pathogenic avian strains, however,Introduction
are cleaved by a family of more widespread intracellular
proteases, resulting in systemic infections. This differ-The influenza virus hemagglutinin biosynthetic precur-
ence in pathogenicity correlates with structural differ-sor HA0 is a glycoprotein held in the viral membrane
ences at the HA0 cleavage site: pathogenic strains haveby a transmembrane anchor sequence near its COOH
inserts of basic amino acids at the site or other sequenceterminus. Its cleavage results in the formation of the two
modifications in its vicinity (Webster and Rott, 1987;disulfide-linked subunits HA1 and HA2, eliminating an
Klenk and Rott, 1988; Klenk and Garten, 1994). The HA0arginine residue, R329, that separates them in the pre-
structure reported here defines the precursor cleavagecursor (reviewed in Wiley and Skehel, 1987). The newly
site of a human influenza hemagglutinin.created amino terminal of HA2 is a nonpolar sequence
Recombinant HA0 was expressed with a mutatedcalled the fusion peptide. Cleavage is essential for in-
fectivity (Klenk et al., 1975; Lazarowitz and Choppin, cleavage site (R329Q) and trypsinized off the surface of
1975) as it activates the potential of the HA to undergo CV-1 cells to form a crystallizable, soluble ectodomain
a low-pH-induced, irreversible conformational change in (R329Q HA0s). Biochemical evidence is presented that
endosomes required for viral entry by membrane fusion the mutant HA0s undergoes the same low-pH-induced
(Maeda and Ohnshi, 1980; Skehel et al., 1982; Wiley and conformational change after cleavage as wild-type HA0.
Skehel, 1987; Godley et al., 1992). Intracellular cleavage The X-ray structure of the mutant HA0s shows how varia-
correlates with virus pathogenicity (reviewed in Webster tion in the structure of the precursor cleavage site leads
to variation in the pathogenicity of viruses. Comparison
with cleaved BHA provides new evidence for the origin‖ To whom correspondence should be addressed (e-mail: dcw
of the metastability and sensitivity to low pH of theadmin@crystal.harvard.edu).
# These authors contributed equally to the work. conformation of HA formed after HA0 cleavage.
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Results
Biochemical Characterization of Mutant R329Q HA0
The precursor HA0 is susceptible at or near the cleav-
age site (Arg-329) to numerous proteases. To prepare
soluble HA0 (HA0s), which requires proteolytic removal
of a membrane anchor sequence, we constructed a mu-
tant in which arginine 329 was replaced by glutamine,
R329Q, to prevent tryptic cleavage at the precursor site,
and a 14 residue sequence containing multiple protease
recognition sites (Germino and Bastia, 1984) was in-
serted immediately before the transmembrane anchor
sequence. Efforts to prepare soluble trimers of HA0 by
secreting HA0s monomers failed to generate trimeric
molecules efficiently. We produced a recombinant vac-
cinia virus containing this mutant HA gene and released
soluble R329Q mutant HA0 from the membranes of re-
combinant-infected CV-1 cells by digestion with trypsin.
Biochemical and immunological data indicate that sol-
uble R329Q HA0s is closely similar to wild-type HA0.
Both molecules are trimeric as judged by sedimentation
(Figure 1A) and are antigenically indistinguishable in
their reactivities with a panel of monoclonal antibodies
at neutral pH or following incubation below fusion pH
(pH 5.0). The protease bromelain cleaves HA0 at G330
instead of R329 (Steinhauer et al., 1995). HA cleaved in
this way is not fusion active (because HA2 lacks Gly-1)
but nevertheless undergoes changes in conformation
characteristic of those required for membrane fusion
activity. On incubation at fusion pH, bromelain-cleaved
R329Q HA0s aggregates and becomes susceptible to Figure 1. Protease Susceptibility of Bromelain-Cleaved R329Q HA0s
after Incubation at Low pHtrypsin digestion as observed earlier for wild-type HA
(e.g., Figure 4 in Skehel et al., 1982). The products of Soluble R329Q HA0s (membrane anchor removed by trypsin) was
digested with bromelain (1 mg/ml, 50 mM b-mercaptoethanol, 10digestion can be separated by sucrose density gradient
mM Tris [pH 8.0], 378C, 2 hr), producing HA2 without the NH2-centrifugation into aggregated HA2 and a soluble HA1
terminal glycine (Steinhauer et al., 1995). Bromelain-cleaved andfraction that reveals cleavages within HA1 at Lys-27 and
uncleaved preparations were incubated at pH 5.0 for 10 min at 378C,
Arg-224 in both wild-type and R329Q HA (cf. Figure 1B and after neutralization, digested with trypsin (10 mg/ml, 10 mM Tris
to Figure 4 in Skehel et al., 1982). By contrast, uncleaved [pH 8.0], 378C, 10 min). The products of digestion were separated by
R329Q HA0s, even after incubation at pH 5.0, sediments sucrose density gradient centrifugation (5.%±20.%) and detected
in fractions from the gradients by SDS-PAGE and immunoblottingas a protease-resistant trimer.
using an anti-HA rabbit serum. HA0 markers (right lane) are soluble
R329Q HA0s (membrane anchor removed by trypsin).
Precursor HA0 Structure
The Cleavage Site
The structure of soluble R329Q HA0s was determined point toward the long a helix of HA2 and the trimer axis
(Figures 2C and 2D). An oligosaccharide is attached atby X-ray crystallography and refined to 2.8 AÊ resolution
(Rcryst 5 .302, Rwork 5 .224) with crystals grown at pH residue 22 of HA1, just 14 AÊ away from the cleavage
point (Figure 2C).7.5. The main chain of only 19 residues, in a sequence
bracketing the cleavage site, is located differently in A Surface Cavity in HA0
There is a deep cavity in R329Q HA0s adjacent to theuncleaved R329Q HA0s relative to BHA (solid bonds in
Figures 2A and 2B; yellow in Figure 2C) (Wilson et al., cleavage site loop (arrow in Figure 3A), which is filled
in cleaved BHA (Figure 3B) by HA2 residues 1±10, a1981; Weis et al., 1990); the remaining residues are es-
sentially superimposable (rms deviation 5 0.49 AÊ for 472 nonpolar segment of the fusion peptide. The cavity con-
tains ionizable residues, including aspartic acids 109residues). The cleavage site 19 residues, (323±328 of
HA1, Q329, and 1±12 of HA2), form a nearly circular loop and 112 on the long a helix of HA2 and histidine 17 of
HA1 (Figure 3C). As a consequence of cleavage, thesein R329Q HA0s (solid bonds in Figure 2A) that projects
the 8 residues that immediately surround the cleavage three ionizable residues are buried without pairing to
other ions; the aspartates (HA2 residues 109 and 112)site, from residue 327 of HA1 to residue 5 of HA2, away
from the surface of the molecule into solvent (arrow in form five hydrogen bonds with the five main-chain amide
groups of residues 2±6 of the fusion peptide of HA2Figure 2C). In R329Q HA0s, HA2 residues 12 to 6 lie
against the molecule, extending down along the surface (Weis et al., 1990), and histidine 17 forms a hydrogen
bond from Ne2 through a water to the carbonyl oxygenand covering the interchain disulfide bond between Cys-
14 of HA1 and Cys-137 of HA2; in cleaved BHA, they of HA2 residue 10 (Figure 3D). Two C-terminal residues
Figure 2. Structure of the Precursor (R239Q HA0s) Cleavage Site before and after Cleavage
(A) Stereo diagram of residues 322±329 and 1±14 of the HA1 and HA2 parts of R239Q HA0s. Residues 323 HA1 to 12 HA2 relocate after
cleavage (solid bonds: HA1, blue; HA2, red); residues 322 and 13±14 (open bonds) occupy the same location before and after cleavage. (B)
Stereo diagram of the same residues (and color code) as in (A) after cleavage (Wilson et al., 1981; Weis et al., 1990). Newly created termini
are 22.5 AÊ from each other.
(C) R329Q HA0s monomer. Cleavage site at arrow. Residues that relocate, 323±329 HA1 and 1±12 HA2, are colored yellow; HA1, blue; HA2, red.
(D) Cleaved HA monomer. Figure prepared with MOLSCRIPT (Kraulis, 1991).
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Figure 3. A Surface Cavity in HA0 Adjacent to the Cleavage Site Is Filled by the Fusion Peptide after Cleavage
(A) Electrostatic surface potential of R329Q HA0s trimer with cavity at arrow. Cleavage site is on the loop between the labeled (red and blue
dots) HA1 C terminal and HA2 N terminal. The cavity surface is approximately 10 AÊ wide and 30 AÊ long.
(B) Cleaved BHA surface showing separation of the newly created termini. Negative electrostatic potential, red; positive, blue. 797 AÊ 2 of
solvent-accessible surface area of the R329Q HA0s cavity and 1380 AÊ 2 of the fusion peptide are buried as a result of the cleavage and
subsequent rearrangement shown in Figures 2 and 3.
(C) Stereo diagram of R329Q HA0s showing the environment of Asp-109 and -112 (HA2) and His-17 (HA1) that are buried in cleaved HA.
(D) Stereo diagram of cleaved HA showing the buried environment of Asp-109 and -112 (HA2) and His-17 (HA1). (Dashed lines are potential
hydrogen bonds.) Figure prepared with GRASP (Nicholls et al., 1991) and RasMol (Collaborative Computational Project, 1994).
of HA1 move out of the top part of the cavity after cleav- D112, K117) have been identified as affecting the pH at
which membrane fusion occurs in mutants selected toage: Glu-325 (HA1) and the side chain of Arg-321 (HA1)
that was hydrogen bonded to Asp-112 (HA2) in HA0 fuse at higher pH (reviewed in Wiley and Skehel, 1987;
Steinhauer et al., 1992). Mutants at Asp-112 are alsoboth move away from the cavity into solution. All of the
ionizable residues in this cavity (HA1: H17; HA2: D109, resistant to some fusion inhibitors (Hoffman et al., 1997).
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Figure 4. Three Conformations of the HA Trimer
(A) Uncleaved precursor R329Q HA0s. Arrow 2 marks cleavage sites and adjacent cavities in each monomer. Residues 323 of HA1 to 12 of
HA2 are yellow. Oligosaccharides shown as balls and sticks; oligosaccharide at Asn-22 of HA1 is labeled.
(B) Cleaved BHA (Wilson et al., 1981). Receptor binding sites marked with arrow 3 (Weis et al., 1988).
(C) Low-pH-induced conformation of thermolysin-solubilized TBHA2 (Bullough et al., 1994). HA1, blue; HA2, red. Disulfide bonds are black
lines. Figure prepared with MOLSCRIPT (Kraulis, 1991).
Three HA Conformations Have Been Determined the aid of the NA structure (von Itzstein et al., 1993) and
may contribute to drug combination therapies effectiveby X-Ray Crystallography
Three conformations of HA have now been defined against the development of resistance.
structurally (Figure 4). These conformations and the in-
terconversion events are potential targets for antiviral Discussion
compounds. The conversion of HA0 to the cleaved con-
formation might be blocked by inhibiting the cleavage Precursor Cleavage
The proteases responsible for cleavage of HA0 in influ-enzymes (arrow 1 in Figure 4) (Garten et al., 1989; Stien-
eke-Grober et al., 1992) or by the binding of an inhibitor enza infections of humans are secreted by cells of the
respiratory tract or by coinfecting bacteria or myco-into the cavity revealed in the R329Q HA0s structure
(arrow 2 in Figure 4) to prevent the insertion of the fusion plasma or may be produced in inflammatory responses
to infection (Klenk and Rott, 1988; Klenk and Garten,peptide. Blocking the conserved receptor binding site
(arrow 3 in Figure 4) (e.g., Watowich et al., 1994 and 1994). A major candidate protease is tryptase Clara,
which is produced by Clara cells of the bronchiolar epi-references therein) or the low-pH-induced conforma-
tional change (arrow 4 in Figure 4) are also strategies thelium (Kido et al., 1992). It is specific for the sequence
Q/E-X-R found at the cleavage site of the HA0s of thethat have been suggested (see Godley et al., 1992 and
e.g., Bodian et al., 1993). Interfering with a transient three known antigenic subtypes of human influenza. No
protease has been identified for the majority of influenzastructure during refolding as demonstrated for HIV-1
gp41 (Wild et al., 1994) or with the membrane fusion viruses (15 antigenic subtypes) that cause enteric and
respiratory infections in waterfowl. It is possible that aprocess itself are also possibilities (arrow 4 or 5 in Figure
4). Compounds that inhibited the functions of the target- requirement for the Q/E-X-R recognition sequence for
replication in the human respiratory tract selects againstrich HA in these ways would add to the collection of
anti-influenza drugs provided by the M2 proton channel infections by avian viruses.
The HAs of the avian viruses that caused the recentinhibitors amantadine and rimantidine (Hay, 1989) and
the anti-neuraminidase (NA) compounds designed with outbreaks of human influenza in Hong Kong contained
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a five-residue insertion of basic amino acids at the site may perturb the structure of HA0 because those resi-
dues are not on the exposed loop. Such perturbationsof cleavage (Subbarao et al., 1998). Such insertions,
which may result from slippage of the RNA polymerase could cause an increase in the accessibility of the cleav-
age site. Site-specific mutant H3 subtype HA0ss withat a particular region of RNA structure (Perdue et al.,
1997), are observed exclusively in the HAs of the H5 increased cleavability are accounted for by the same
mechanisms (Gething et al., 1989; Ohuchi et al., 1989).and H7 subtypes, and their presence correlates with
virulence for chickens (Webster and Rott, 1987; Klenk The susceptibility of HA0 to cleavage correlates with
pathogenicity both in avian infections and in the recentand Rott, 1988; Klenk and Garten, 1994). Cleavage in
these cases is intracellular, and the proteases involved Hong Kong influenza outbreak in humans in which 6 of
the 18 confirmed cases were fatal (WHO, 1998). Thehave been identified as furin and other subtilisin-like
enzymes involved in the posttranslational processing of R329Q HA0s structure provides a structural explanation
for the correlation of precursor cleavage with pathogen-hormone and growth factor precursors. The furin recog-
nition sequence R-X-R/K-R is a frequent insertion at the esis and supports the use of properties that influence
cleavage as markers of virulence in the surveillance ofHA0 cleavage sites of H5 and H7 HAs, and both the
wide tissue distribution of this enzyme and the efficiency influenza viruses.
of intracellular cleavage compared to opportunistic ex-
tracellular cleavage appear to contribute to the wide-
Precursor Cleavage Activates the Potential for thespread and virulent systemic infections of these viruses
Low-pH-Induced Conformational Change(Webster and Rott, 1987; Klenk and Rott, 1988; Klenk
What permits cleaved HA on virus to undergo a low-and Garten, 1994).
pH-induced irreversible conformational change, while
the uncleaved precursor, HA0, does not? It seems possi-
ble from the structure of R329Q HA0s that the movementPrecursor Cleavage and Pathogenicity
The structure of R329Q HA0s revealed that the side chain of the fusion peptide into the cavity in HA0, burying
ionizable residues (Figure 3), may set a low-pH trigger.of P-4 (Lys-326) is packed against the HA0 structure
and would not be accessible for binding into an enzyme In that case, precursor cleavage would be required to
set the pH trigger before the conformational changeactive-site recognition pocket as furins appear to re-
quire. This may explain why furin sites on HAs are always could be induced by low pH. Alternatively, it seems
possible that the covalent bond per se that links HA1four-residue inserts. The structure of R329Q HA0s sug-
gests that the insertion of 4 residues at the cleavage to HA2 in HA0 might restrict the movement of the fusion
peptide, preventing the extensive conformational refold-site will both project the protease recognition site, as a
prominent bulge, into solution and expose the critical, ing observed after low-pH treatment of the cleaved mol-
ecule (Figure 4).inserted P-4 arginine to direct recognition by furin-like
proteases. Similar structures may also be involved at The existence of HA0 molecules with insertions from
4 to 20 residues at the cleavage site (Webster and Rott,the cleavage sites of membrane fusion glycoproteins of
other viruses: paramyxoviruses such as measles, mumps, 1987; Klenk and Rott, 1988; Klenk and Garten, 1994)
raises the question of why, with such long loops, theand respiratory synctial viruses; the filoviruses Ebola
and Marburg; and retroviruses such as HIV-1 and Rous fusion peptide could not move into the HA0 surface
cavity without cleavage, setting the presumptive pH trig-sarcoma virus all have furin recognition sites like intra-
cellularly cleaved influenza HA0. This interpretation is ger and becoming conformationally labile to low pH
without precursor cleavage? The answer may be thatconsistent with the increased cleavability observed for
HAs of two mutants that were selected by replication the HA0 cavity is, in a sense, partially filled. Arg-321,
Pro-324, and Glu-325 all need to move out of the topin tissue culture in the absence of extracellular prote-
ases and that contained in-frame insertions near the portion of the cavity (Figure 3C; residues above arrow-
head in Figure 3A) before the fusion peptide will fit in. Itcleavage site of 18 residues coded by 28S ribosomal
RNA or 20 residues coded by the gene for influenza seems likely that precursor cleavage allows these three
HA1 residues to move away from their location in HA0nucleoprotein (Khatchikian et al., 1989; Orlich et al.,
1994), which would also be expected to project the so that the N-terminal sequence can fill the cavity. As
a consequence, the carboxyl terminus of HA1 and aminocleavage site into solution.
Some H5 influenza strains lack an inserted furin recog- terminus of HA2 are separated by 22 AÊ in cleaved HA
(Wilson et al., 1981). The prominent negative electro-nition site but are still highly pathogenic. These viruses
either lack an oligosaccharide at Asn-11 (Kawaoka et static charge of the cavity (red in Figure 3A) suggests
the possibility that the newly cleaved positively chargedal., 1984) (the H5 subtype homolog of Asn-22 in X31
HA; Figures 2C and 3A) or contain basic amino acid N-terminal amino group may provide an electrostatic
force to guide the docking of the fusion peptide. Thesubstitutions at P-5 and P-6 (Webster and Rott, 1987;
Ohuchi et al., 1989; Vey et al., 1992). The former observa- existence of such an electrostatically charged cavity on
the surface of HA0 suggests that a charged peptide ortion is consistent with the proximity of this oligosaccha-
ride to the cleavage site in R329Q HA0s (14 AÊ ) (Figure mimetic might bind in this pocket on HA0 and block the
formation of the cleaved HA conformation and hence3A), which, as noted earlier (Kawaoka et al., 1984; Desh-
pande et al., 1987; Kawaoka and Webster, 1989), could block infectivity. Following cleavage, at equilibrium, the
covalently attached fusion peptides might be expectedinfluence the accessibility of a protease to the cleavage
site. The structure of R329Q HA0s suggests that the to saturate the pockets because of their high local con-
centration, but an inhibitor may still be effective if itsubstitutions made at P-5 and P-6, in the latter report,
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slowed the conformational rearrangement in Figures 2C homologous to His-17 in the HA amino acid sequence,
is completely buried behind the fusion peptide of HEFand 2D. The transient, and unstable, intermediate follow-
ing cleavage with the fusion peptide exposed might ei- in the cleaved HEF structure. Its e-amino group makes
only two hydrogen bonds with its noncharged neigh-ther aggregate or undergo an off-path conformational
alteration, resulting in loss of activity. bors, suggesting that it may be uncharged, with a de-
pressed pKa similar to those in the model proteins dis-Changes in pH have a different effect on HA0 than on
cleaved HA due to the different environments of ioniz- cussed above (Dao-pin et al., 1991; Stites et al., 1991;
Garcia-Moreno et al., 1997). The structure of uncleavedable residues in the two structures (Figures 3C and 3D).
Residues on the surface of the HA0 cavity exposed to HEF (HEF0) is not known, so it is not known whether
Lys-9 is on the surface of a cavity in that conformation.solvent can change electrostatic charge at their appro-
priate pKa without affecting the fold of the protein; such Membrane fusion of many enveloped viruses is medi-
ated by glycoproteins that are synthesized, folded, andsurface charges are largely shielded by solvent and
counterions. Once buried in HA, after cleavage of HA0, oligomerize as a precursor that then must be cleaved
to be activatable. In influenza virus, proteolytic cleavagethese ionizable residues (His-17 of HA1 and Asp-109
and -112) have the potential to disrupt the structure if of the envelope glycoprotein precursor HA0 primes the
molecule for a subsequent low-pH-induced conforma-they gain or lose protons. Examples from site-directed
mutations of model proteins, where lysine was placed tional change (Figure 4). The cleavage generates an ap-
parently metastable cleaved HA conformation that lowin a buried location in Staphylococcal nuclease, in a
hyperstable mutant of Staphylococcal nuclease, and in pH induces to refold into a conformation stable at both
neutral and low pH, this low-pH-induced refolding eventlysozyme, all showed a strong pH dependence of protein
stability, with the molecules becoming unstable as the being required for membrane fusion. Other viruses, for
example retroviruses like HIV-1, also synthesize an en-lysine became charged at its depressed pKa (due to
burial) near pH 6.0 (Dao-pin et al., 1991; Stites et al., velope glycoprotein gp160 that must be cleaved (gp120,
gp41) to adopt a conformation that requires further1991; Garcia-Moreno et al., 1997).
If we assume, for the sake of discussion, that the Asp- structural changes before fusing membranes. In this
case, the membrane-fusion conformational change is109, -112, and His-17 are not protonated in cleaved HA
at pH 7.0 (if one is protonated at pH 7.0, it will have no triggered by binding to receptor and in some cases
coreceptor proteins, rather than low pH (Sattentau andeffect when the pH is lowered), then lowering the pH
could protonate them, depending upon their pKas in Moore, 1991). It is likely that in these other cases, the
precursor molecules will also contain surface cavitiesthe buried environment of cleaved HA. Protonating the
aspartic acids would eliminate some of their capacity or features as in R329Q HA0s that will be occupied only
after precursor cleavage and that may present targetsas acceptors for hydrogen bonds (Figure 3D), but most
of the hydrogen bonds would be preserved because on the precursor or during cleavage that might bind
analogs of the fusion peptide to prevent the cleavedeven a protonated carboxylate can accept three hydro-
gen bond donors. If His-17 becomes protonated while molecule from adopting a structure with membrane fu-
sion potential.completely buried by the fusion peptide in cleaved HA,
the resulting buried positive charge might be destabiliz-
Experimental Proceduresing. The pKa for this buried histidine would be expected
to be depressed. Once charged, the histidine, which up
Protein Expression, Purification, and Characterizationto then had been helping to hold HA together (Figures
Site-specific mutagenesis, cloning of mutated genes for HA into a
3C and 3D), could be a strong force pushing it apart. vaccinia expression vector containing the cowpox p160 late pro-
Mutant virus with Asp-112 (HA2) and His-17 (HA1) moter, and generation of recombinant vaccinia viruses were as de-
substitutions undergo the pH-induced conformational scribed (Steinhauer et al., 1995).
Vaccinia-HA0 R329Q recombinant-infected CV-1 cells in 10 mMchange at higher pH than wild-type, indicating a role
Tris (pH 8.0) were homogenized in a Dounce homogenizer. Thefor these residues in either stabilizing the neutral pH
suspension was made 70% w/v in sucrose, overlaid with 10 mMstructure, triggering the low-pH-induced conformational
Tris (pH 8.0), and centrifuged for 2 hr at 25,000 rpm in a Beckman
change, or both (Daniels et al., 1985; Wiley and Skehel, SW27. The membrane fractions separated by flotation were pelleted
1987). Unfortunately, interpreting mutant data in this by centrifugation at 25,000 rpm for 60 min. Membranes resuspended
context is very uncertain. A single residue can have in 10 mM Tris (pH 8.0), 10 mM calcium chloride, and 5 mM magne-
sium chloride (109 cell equivalents/10 ml) were incubated in 50 mg/many roles in each conformation; e.g., in the X-ray struc-
ml trypsin (Sigma) and 1 U/ml DNase (Promega) at 378C for 30 min.tures of HA0 and cleaved HA, His-17 appears situated
Membranes were pelleted by centrifugation at 50,000 rpm for 10to stabilize HA0 at any pH and to stabilize cleaved HA
min in a Beckman TL100, and the supernatant was incubated with
above its pKa. 25 mg/ml C. perfringens neuraminidase (Boehringer) at 378C for 30
min. The mixture was then overlaid on a 10%±30% sucrose gradient
in 10 mM Tris (pH 8.0) and centrifuged for 16 hr at 38,000 rpm in a
Other Viral Membrane Fusion Proteins Beckman SW41. Sucrose was removed from HA0-containing frac-
tions during ultrafiltration through a Millipore PM10 membrane filter,Recently, the structure of the cleaved conformation of
and HA0 was further purified by binding to a Q15 Sartorius ion-the hemagglutinin-esterase-fusion glycoprotein (HEF) of
exchange column in 10 mM Tris (pH 8.0) and eluting in 150 mMinfluenza C virus has been determined by X-ray crystal-
NaCl in 10 mM Tris (pH 8.0).
lography at neutral pH (Rosenthal et al., 1998; Zhang et
al., submitted). Despite only 12% sequence identity with Crystallization and X-Ray Data Collection
influenza A HA, the structures, especially in the HA2/ R329Q HA0s crystals were grown in hanging drops from 15% PEG
4000, 75 mM NaCl, 50 mM HEPES (pH 7.5), and 0.1% NaN3. CrystalsHEF2 regions, are remarkably similar. Lysine 9 of HEF,
Cell
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